Skip to main content

Handelsbanken Fonder AB

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1398318 STOCKHOLM, V7

Position in CLDX

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$1,012,112
+$190,564 QoQ
Shares Held
27,200
+5.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#126
of 252 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. CLDX ranks #69 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,012,112 27,200
2026-03-31 $821,548 25,900
2025-12-31 $703,444 25,900
2025-09-30 $558,792 21,600
2025-06-30 $439,560 21,600
2025-03-31 $382,965 21,100
2024-12-31 $533,197 21,100
2024-09-30 $469,062 13,800
2024-06-30 $414,512 11,200
2024-03-31 $339,957 8,100
2023-12-31 $321,246 8,100
2023-03-31 $208,684 5,800
2022-12-31 $258,506 5,800
2022-09-30 $250,179 8,900
2022-06-30 $239,944 8,900
2022-03-31 $303,134 8,900
2021-12-31 $343,896 8,900